NT 100

Drug Profile

NT 100

Alternative Names: NT-100

Latest Information Update: 11 Apr 2017

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator Nora Therapeutics
  • Class Chemoprotectants; Granulocyte colony-stimulating factors; Infertility therapies; Neuroprotectants
  • Mechanism of Action Immunomodulators
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

  • New Molecular Entity Yes

Highest Development Phases

  • Phase II Female infertility

Most Recent Events

  • 25 Aug 2016 Phase-II development is ongoing in United Kingdom
  • 06 Jun 2016 Nora Therapeutics completes the phase III RESPONSE trial for Female infertility in United Kingdom (EudraCT2014-000084-40)
  • 01 Sep 2015 Nora Therapeutics completes a phase II follow-up trial in Female infertility in USA (NCT01978561)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top